Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Recipharm AB has signed two separate agreements to acquire Kemwell’s pharmaceutical contract development and manufacturing (CDMO) businesses.
read more
JSR Corporation has announced the formation and establishment of its Life Sciences Division, JSR Life Sciences (JLS).
read more
Sunny Pharmtech Inc., a Taiwan-based API and finished-dose drug development company, and Vitruvias Therapeutics, a generic drug development company, have signed two additional agreements to co-develop and market two additional high-value generic ...
read more
Wednesday, April 20, 2016
Pfizer’s combined contract manufacturing organization, officially launches today. The multi-specialty CMO focuses on API synthesis and sterile injectables fill-finish.
read more
Wednesday, April 20, 2016
Bemis Company has signed a definitive agreement to acquire the medical device packaging operations and related value-added services of SteriPack Group, a global manufacturer of sterile packaging solutions for medical device and pharmaceutical ...
read more
Wednesday, April 20, 2016
Innophos Holdings, Inc. has announced the appointment of Amy Hartzell as Vice President, Supply Chain and Purchasing, which was effective April 13, 2016.
read more
Wednesday, April 20, 2016
PCI Synthesis, Inc. has announced the formation of its cGMP Advanced Polymer Development and Manufacturing Group, which is currently developing and manufacturing more than a dozen advanced polymer-based projects.
read more
Wednesday, April 20, 2016
Biologics Consulting, a full-service regulatory and product development consulting firm for biologics, pharmaceuticals and medical devices, has announced the launch of its Clinical Trials Planning and Oversight Group.
read more
Aptuit, LLC has acquired Exquiron Biotech AG to meet customer demand for fully integrated outsourced discovery services. Exquiron is a leading specialist Contract Research Organization dedicated to early phase drug discovery solutions.
read more
JSR Micro has expanded the JSR Life Sciences business division by becoming the majority shareholder of Boston area-based MBL International Corporation (MBLI). Tim Lowery, Sr. Vice President of Emerging Technologies at JSR Micro, Inc., has been ...
read more
Evotec has announced a multi-year compound management agreement with Pierre Fabre Laboratories, the second largest private French pharmaceutical group.
read more
Famar has announced the planned acquisition of the Pointe-Claire, Quebec, a manufacturing site from the Consumer Health Division of Bayer.
read more
Medidata a provider of cloud-based solutions for clinical research in life sciences, has announced that Bristol-Myers Squibb has selected the Medidata Clinical Cloud® to help manage, monitor and analyze its clinical trials.
read more
Smithers Avanza, a contract research organization (CRO) supporting the pharmaceutical industry, announced that its Bioanalytical Services Division has Clinical Laboratory Improvement Amendments (CLIA) certification.
read more
Lannett Company has announced plans to co-develop a generic insulin pharmaceutical product for the U.S. market with its strategic partner in China, YiChang HEC ChangJiang Pharmaceutical Co., Ltd, an HEC Group company.
read more